Jul 16, 2020 / 01:00PM GMT
Operator
Hello and welcome to the Orexo Interim Reports Q2 2020. (Operator Instructions) Today, I'm pleased to present Nikolaj Sørensen, CEO; and Joseph DeFeo, CFO. Please begin your meeting.
Nikolaj Sørensen - Orexo AB(publ)-President&CEO
Thank you very much and welcome to the second interim report. I will also say we have received some questions through e-mails and Lena Wange, who is our Investor Relations Director, who will join the call in the end for the Q&A session and ask these questions if they have not already been asked or addressed during the presentation.
So this quarter has, in many ways been a very exciting quarter for Orexo. We have invested into a completely new area in digital therapies where we, due to the circumstances with the COVID-19 pandemic, have had an opportunity and also both commercially and regulatory, to accelerate the launch of vorvida and for deprexis. We have also, during the quarter, seen that our R&D pipeline has progressed according to plan. And
Q2 2020 Orexo AB Earnings Call Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot